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Schistosoma mansoni is a well-adapted blood-dwelling parasitic helminth, persisting for decades in its human host despite
being continually exposed to potential immune attack. Here, we describe in detail micro-exon genes (MEG) in S. mansoni,
some present in multiple copies, which represent a novel molecular system for creating protein variation through the
alternate splicing of short (#36 bp) symmetric exons organized in tandem. Analysis of three closely related copies of one
MEG family allowed us to trace several evolutionary events and propose a mechanism for micro-exon generation and
diversification. Microarray experiments show that the majority of MEGs are up-regulated in life cycle stages associated
with establishment in the mammalian host after skin penetration. Sequencing of RT-PCR products allowed the description
of several alternate splice forms of micro-exon genes, highlighting the potential use of these transcripts to generate a complex
pool of protein variants.We obtained direct evidence for the existence of such pools by proteomic analysis of secretions from
migrating schistosomula and mature eggs. Whole-mount in situ hybridization and immunolocalization showed that MEG
transcripts and proteins were restricted to glands or epithelia exposed to the external environment. The ability of schisto-
somes to produce a complex pool of variant proteins aligns them with the other major groups of blood parasites, but using
a completely different mechanism. We believe that our data open a new chapter in the study of immune evasion by schis-
tosomes, and their ability to generate variant proteins could represent a significant obstacle to vaccine development.
[Supplemental material is available online at http://www.genome.org. The sequence data from this study have been
submitted to GenBank (http://www.ncbi.nlm.nih.gov/genbank) under accession nos. GU258169–GU258219. The micro-
array data from this study have been submitted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)
under accession nos. GSE22037 and GPL10466. The proteomic data from this study have been submitted to the Pro-
teomics Identification Database (http://www.ebi.ac.uk/pride/) under accession nos. 12831–12859 and 12873–12878.]
Schistosomes are blood-dwelling helminth parasites that represent
a serious health problem in tropical regions, affecting approxi-
mately 200 million people. They can persist in the bloodstream
for decades despite being permanently exposed to the host im-
mune system, indicating that they must deploy a very effective
system of immune evasion. Despite intensive studies of the host–
parasite interaction, how the parasite succeeds in avoiding immune
attack is not fully understood. One component involves the pro-
duction of a relatively inert barrier at the surface of the tegument,
the major interface between the parasite and host. This comprises
a conventional plasma membrane overlain by a membrane-like
secretion, the membranocalyx, which is believed to shield para-
site proteins from the immune attack (Skelly and Wilson 2006).
In contrast, the other major groups of blood-dwelling parasites,
exemplified by Trypanosoma brucei and Plasmodium falciparum,
usemolecularmechanisms that involve both protein variation and
polymorphism, to evade host immune responses.T. brucei relies on
switching expression of multicopy genes during the course in-
fection, to produce a unique dominant but immunogenic surface
glycoprotein (Taylor and Rudenko 2006). As the host mounts an
antibody response to eliminate the parasites from the circulation,
a new dominant variant appears in a virtually endless succession
of parasite populations. P. falciparum employs clonal variation too,
switching the expression of protein isoforms encoded by large
gene families, on the surface of infected erythrocytes (Kyes et al.
2007). The parasite also possesses multiple alternative allelic forms
at single loci that encode key merozoite antigens (Anders et al.
1993). In both cases, the proteins provoke immune responses that
are circumvented by the parasites’ capacity for protein variation.
Micro-exons are very short exons (#36 base pairs [bp]) that
have been described in a few genes (ranging from 0.5% to 1.6% of
total genes) from the genome of several organisms; in most cases
a single micro-exon was detected per gene (Volfovsky et al. 2003).
Micro-exons have been previously described in S. mansoni in
a portion of the gene for the antigen 10.3 in which 27-bp exons
made up repeats of 81 bp found in tandem (Davis et al. 1988).
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However, the lack of its genomic sequence prevented a description
of its complete structure. Recently, Chalmers et al. (2008) also de-
scribed a structure containing some micro-exons in the SmVAL-6
gene and showed alternative use of such exons in the generation of
transcripts.
Our attentionwas first drawn to a group of unusual S. mansoni
genes of diverse sequence during a proteomic search of schistosom-
ula secretions, which identified peptides with homologies with
an EST contig Sm11845 that mapped to a predicted coding region
in the v1 genome assembly, now designated Smp_138080. We
noted that the structure of this gene uniquely comprised very short
internal symmetrical exons. By further analysis of the genome
assembly, using the methodology developed to detect single micro-
exons (Volfovsky et al. 2003), we found 27 genes with the same
organization, which we named micro-exons genes (MEGs). A one-
paragraph preliminary description was included in the recent pub-
lication of the S. mansoni genome (Berriman et al. 2009). A full ac-
count is presented here showing details of how micro-exon genes
undergo alternative splicing to generate multiple transcripts, to-
gether with proteomic and localization data. These indicate that
the multiple protein products generated by MEG transcripts are
secreted from glands and epithelia, a situation whichwould allow
them to interact with the host immune system. These data high-
light a novel system to create protein variation in a blood-dwelling
helminth parasite.
Results
Micro-exon genes from schistosomes represent a novel group
of genes with unique features
Analysis of genes differentially expressed in the microarray ex-
periment permitted us to pinpoint a further four gene familieswith
micro-exon structure in the S.mansoni genome (MEG-15–MEG-18),
additional to those briefly described by us (Berriman et al. 2009).
The nonannotated Smp gene models from the day 3 schistosom-
ulum-germ ball comparisons were extracted from the top table of
array results and ordered by fold-difference in expression. Simple
visual inspection of the unspliced DNA sequence on the sequence
page for each gene at GeneDB, version 2.1, revealed the micro-
exon structure. Four genes with list positions 9, 10, 18, and 24,
and differences of 33-, 18-, 15-, and 14-fold in expression were
identified in this way.
We classified the 31 predicted MEGs by protein sequence
homology into 18 families (alignment
with E-value lower than 104 in a BLASTP
using all MEG proteins as database and
queries). We then performed a BLASTN
search of the S. mansoni genome assembly
using the 31 known cDNAs, to find any
further family members missed by the
Volfovsky method (Volfovsky et al. 2003).
This permitted the mapping of exons dis-
playing similar sequences to the previ-
ously described MEGs and revealed a total
of 72 micro-exon genes, probably an
underestimate because the genome as-
sembly is incomplete. The 18 families di-
vide into two groups, 11 with single and
seven with multiple members, the gene
complement of the latter ranging from 2
to 23 (average = 8.7). The vast majority of
micro-exons (;92%) in all families are symmetrical, ranging in size
from 6 to 36 bp (with two outliers at 51 bp), the commonest fre-
quency being 21 bp (Fig. 1A). A small number of micro-exons (24/
289) are not symmetrical. The majority of these are near the ex-
tremities of the genes, where they code either for part of the signal
peptide that is not expected to vary, or near the stop codon, with
a minimal disruptive potential for frameshift caused by their al-
ternative splicing (Supplemental Fig. 1). Additionally, there is
a small number (17) of larger internal exons ranging from 37 to 61
bp (Fig. 1B). The flanking exons, including untranslated regions
(UTRs) deduced from EST sequences, range from 22 to 274 bp
(average = 120 bp) (Fig. 1B). However, it is important to note that
most of the UTR from 59-end exons are incompletely sequenced so
flanking exon sizesmay actually be bigger than currently perceived.
These flanking exons do not contain much coding sequence, rep-
resenting on average only 27% of the total bases coding for amino
acids in the genes. Despite their small size, the micro-exons use the
same mRNA splicing mechanism as conventional genes, with con-
served 59 and 39 canonical splicing sites (Supplemental Fig. 2) in the
respective introns. Indeed, the 59 site of the micro-exon introns is
even more conserved than that of conventional genes.
All MEGs code for small (6–20 kDa) predicted proteins but
BLASTP searches of the NCBI nr database revealed no homology
with proteins of known function in other genera. Furthermore, no
conserved domains were identified by programs such as Prosite,
Interpro, and SMART. However, SignalP analysis predicted an
N-terminal leader sequence for almost all MEG proteins (Table 1).
The prediction of leader sequence combined with the absence in
all but three families of additional membrane spanning regions
predicted by HMMTOP lead us to conclude that most of the MEG
proteins are secreted.
We performed an exhaustive search in platyhelminths for
homologs of protein sequences encoded by the micro-exon genes.
ESTs databases fromall platyhelminths deposited at GenBank, plus
separate databases for Fasciola hepatica (; 25,000 EST contigs),
S. haematobium, Echinococcus multilocularis, and E. granulosus (the
last three obtained from WTSI: http://www.sanger.ac.uk/Projects/
Helminths/) and genome sequences from S. japonicum (Zhou et al.
2009), Schmidtea_mediterranea (The Schmidtea mediterranea Se-
quencing Consortium), and E. multilocularis (WTSI) were used as
databases for BLASTN and BLASTX searches with transcripts and
protein products from all 18 MEG families, respectively. We found
significant hits only for nine MEG families among S. japonicum
ESTs and 11 MEG families among S. haematobium ESTs. Further
Figure 1. Exon size distribution in S. mansoni micro-exon genes. (A) Histogram of the symmetrical
internal exon size distribution. (B) Histogram of asymmetrical internal exon and flanking exon sizes.
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analysis of the S. japonicum genome indicates that MEGs in this
species have similar structure, with small symmetrical exons, to
those verified in S. mansoni. Alignment of S. haematobium MEG
ESTs with available 454 reads from a preliminary genome sequenc-
ing effort (available at http://www.cebio.org/projetos/schistosoma-
haematobium-genome) suggest that a similar structure is also pres-
ent in this parasite, but the fragmentary nature of the sequences
currently prevents us from clearly defining themicro-exon structure
of any genes.
Evolution of micro-exon genes
In order to understand better the evolution of micro-exon genes,
the MEG-3 family was chosen since it contained multiple closely
related members, well described in the assembled genome se-
quence. Figure 2 illustrates the structure of the four members of
this family that form a gene cluster on a chromosome (Fig. 2A).
Alignment of the protein products using BLASTP indicates that the
first three members have ;60% identity and 70% positive amino
acids, with a fourth more divergent member (MEG-3.4; ;25%
identity and 40%positive).We interpret this organization to be the
result of a series of gene duplications, one of them an inversion,
withMEG-3.4 the first to diverge andMEG-3.2 andMEG-3.3 being
the more closely related elements (Supplemental Fig. 3A). Due to
the high similarity between the MEG-3.1, MEG-3.2, and MEG-3.3
gene sequences, we were able to align them to obtain further in-
sights into the evolution of micro-exon genes. The number and
size ofmicro-exons is largely conserved (Fig. 2B), implying a strong
Table 1. Classification and characterization of MEG families
Family
No. of
members Examplea
Symmetrical exons in
coding regionb
Exons #36 bp
in coding regionb
Leader
sequence
MEG-1 6 Smp_122630 12/13 9/13 (51) Y
MEG-2 (ESP15) 23 Smp_159800 11/12 12/12(27) Y
MEG-3 (Grail) 4 Smp_138080 19/19 19/19 (27) Y
MEG-4 (10.3) 2 Smp_163630 16/18 18/18(27) Y
MEG-5 1 Smp_152580 5/6 5/6 (37) Y
MEG-6 1 Smp_163710 9/9 9/9 (24) N
MEG-7 1 Smp_165050 7/8 6/8 (61) Y
MEG-8 2 Smp_172180 14/15 15/15 (33) Y
MEG-9 1 Smp_125320 4/5 5/5 (25) Y
MEG-10 1 Smp_152590 3/4 4/4 (22) Yc
MEG-11 1 Smp_176020 7/8 8/8(21) Y
MEG-12 1 Smp_152630 5/5 5/5 (21) NAd
MEG-13 1 Smp_127990 5/5 5/5 (36) NAd
MEG-14 1 Smp_124000e 12/13 13/13(27) Y
MEG-15 1 Smp_010550 11/12 10/12 (39) Y
MEG-16 1 Smp_158890 8/9 7/9 (57) Y
MEG-17 19 Smp_180620 6/8 8/8 (30) Y
MEG-18 5 Smp_032560 4/4 4/4 (36) Y
aSequences are accessible using Smp ID number in GeneDB (http://www.genedb.org/genedb/smansoni/).
bExcluding the ~59- and 39-end flanking normal sized exons.
cSignal peptide predicted with confidence >50% using SignalP-HMM but with only two out of five positive parameters in SignalP-NN.
dPartial sequence lacking EST evidence to deduce the 59 large exon containing an initial methionine.
e59 portion of the sequence detected as secreted using signal trap methodology in Smyth et al. (2003).
Figure 2. Structure of micro-exon genes in the MEG-3 family. (A) Schematic representation of the position of four MEG-3 genes on a chromosome. (B)
Structure of the fourMEG-3 familymembers.Wide portions represent exonswhile narrowportions represent introns. Figure is to scale, but exons are depicted
three times larger than introns to permit better visualization. Numbers above micro-exons indicate length in base pairs. Letters indicate homologous exons
between the different members. Homology between MEG-3.1, MEG-3.2, and MEG-3.3 has been determined by genomic sequence alignment. Proposed
homology betweenMEG-3.4 and the other genes has been determined by protein alignment, the similarity of exon positions in the gene and by their length.
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evolutionary pressure to maintain structure. Nonetheless, some
differences are evident, with acquisition and loss of micro-exons
during the history of this family (Supplemental Fig. 3A).
A variation in the length of homologous micro-exons is de-
tectable at the exons s and r (Fig. 2). A more detailed analysis of
those sequences shows that variation in length of exon s was
caused by two point mutations (Supplemental Fig. 3B). Consider-
ing that MEG-3.4 (12 bp in length for the same exon) must rep-
resent an ancestral state, it is possible to hypothesize that after its
divergence, the original 12-bp exon was transformed into a 24-bp
exon by the ancestral introduction of a stronger splicing acceptor
site (condition illustrated byMEG-3.3 andMEG-3.2); the ancestral
acceptor site was then destroyed by a point mutation in MEG-3.2.
However, MEG-3.1 appears to have undergone an additional mu-
tation that caused the loss of the newer stronger splicing signal and
reversion of the exon to its former state. Another point mutation
is responsible for the conversion of the 21-bp exon r present in
MEG-3.1 andMEG-3.4 into a 27-bp exon inMEG-3.3 (Supplemental
Fig. 3B).
The most remarkable instance is the gain of two 9-bp exons
just after the portion encoding the signal peptide (Fig. 2, exons b1
and b2). After divergence from MEG-3.3, the ancestor of MEG-3.1
and MEG-3.2 must have undergone an insertion (;1.2 kb) that
contained the 9-bp sequence of that exon (G1-I1 and G2-I1 in
Supplemental Fig. 4). We could not find any locus in the genome
displaying a similar sequence, so we assume that a recombination
event must have excised this sequence from its original position
and transferred it to the MEG-3 gene. It remains to be determined
whether this 9-bp exon was originally part of another micro-exon
gene or appeared by chance after integration of this genomic
portion into theMEG-3 gene. The second insertion in theMEG-3.1
gene (G1-I2 in Supplemental Fig. 4) has a smaller size (;400 bp)
and a high similarity to G1-I1 and G2-I2 (Supplemental Fig. 4). In
addition, this second insertion is flanked by transposons with
traits similar to the previously described Sm-alpha retroposon
(Ferbeyre et al. 1998), such as the presence of a hammerhead
ribozyme, being in that regard similar to the structure detected in
some viroids of plants (Flores et al. 1999). We hypothesize that the
insertion of such an element into the MEG-3.1 gene may have
caused a double-strand break, and during the repair process a por-
tion of the G2-I1 containing the 9-bp
exon was copied, which would explain
the high similarity between G1-I2 and
G2-I1. We can infer that this is a series of
exon gains, rather than deletions, be-
cause the more divergent ancestralMEG-
3.4 contains only one 9-bp exon. In ad-
dition, it is possible to note thatMEG-3.2
contains one fewer micro-exon near the
end of the gene, relative to MEG-3.1 and
MEG-3.3 (exon r, Fig. 2), due to a deletion
of a portion of ;1.3 kb.
Transcription of most micro-exon
genes is up-regulated in the
intramammalian stages
of the parasite
Analysis of all available EST data, by life
cycle stage (Supplemental Table 1) in-
dicates that MEGs are mostly transcribed
in intramammalian stages of the parasite
and in some cases in cercariae and germ balls, but are practically
absent from miracidia, except for MEG-18. Probing of the oligo-
nucleotide array with double-stranded cDNA from the three life
cycle stages associated with infection of the mammalian host
revealed numerous MEG transcripts among the genes showing the
greatest change in expression, particularly in the day 3 schistosom-
ula, but also in the germ balls and cercariae (Fig. 3). Only three of
the 18 MEG families (MEG-1, MEG-6, and MEG-11) showed no
variation in the three life cycle stages. Expression ofMEG-1was low,
whereasMEG-6 was high in all three life cycle stages studied;MEG-
11was not detected (data not shown). Transcripts forMEG-7,MEG-
10, andMEG-18 were highly expressed in the germ balls relative to
the cercariae and schistosomula. It is notable thatMEG-7 andMEG-
10were the only two for which ESTs generated from germballs were
found in public databases (Supplemental Table 1). Transcripts for
MEG-13 were most highly expressed at the cercarial stage, while
both MEG-4 genes were highly expressed in cercariae and schisto-
somula (up ;50-fold) relative to the germ ball. All the remaining
MEGs were most highly expressed in the schistosomulum, with
MEG-8 (both genes), MEG-12 (one gene), MEG-14, MEG-15, and
MEG-16 also having appreciable gene expression in cercariae.MEG-
2 (six genes), MEG-3 (four genes), MEG-5, and MEG-17 were exclu-
sively up-regulated in the day 3 schistosomulum, relative to the
preceding stages. We have also been able to detect high expression
of genes from four different MEG families (MEG-2,MEG-3,MEG-17,
andMEG-18) in eggs when compared with cercariae (Supplemental
Table 2).
Micro-exon genes display stage-dependent alternative splicing
The occurrence of multiple symmetrical exons would allow one or
more to be excised without altering the reading frame. MEG or-
ganization therefore clearly favors segmentation of virtually the
whole coding region into short modules that might be differen-
tially assembled, potentially to produce diverse protein structure.
To investigate this possibility, we selected three MEG families
(MEG-1,MEG-2, andMEG-3) to explore in detail, for two of which
we had protein secretion data. RT-PCR was performed with prim-
ers designed for flankingexons to amplify transcripts. For each fam-
ily, sampling of transcripts showed a diversity of products upon
Figure 3. Detection of MEG expression using microarrays. Expression of MEG transcripts detected by
hybridization of double-stranded cDNA from intramolluscan germ balls, infective cercariae and day 3
skin-stage schistosomula, to a genome-wide oligonucleotide array. Fold differences in level of ex-
pression are plotted relative to the lowest value, irrespective of stage, which is taken as unity. The triple
bar groups are arranged by the stage in which highest expression was found and by their MEG family.
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acrylamide gel separation (Supplemental Fig. 5A–C). It is also
possible to note considerable specificity in MEG family expression
with the absence of transcription of these selected genes in some
stages and different amplification profiles between stages. Se-
quencing of randomly selected clones from the PCR products
confirmed the existence of several transcripts for different
members of the studied families. Mapping of these to the genome
showed they originated by alternative splicing of micro-exons
(Fig. 4; Supplemental Figs. 6–8). The presence of 14 cysteines in
MEG-3 proteins implies a complex folded structure for the
expressed protein and their position represents a highly conserved
feature (Supplemental Fig. 9).
All four genes of the MEG-3 family are actively transcribed
with three, 10, three, and two variants detected, respectively. Due
to the micro-exon symmetry, in only one of 17 transcripts was an
early stop codon introduced by splicing of an asymmetric long
exon. Even more remarkable, in four cases asymmetric exons
shifted the reading frame generating a novel and extended region
(Fig. 4; Supplemental Fig. 10). In the other families studied the
effect of alternative splicing of the micro-exon genes on the pro-
teins coded was similar to that observed withMEG-3 (Supplemental
Figs. 11, 12).
The impression of the MEG transcription profile gained by
visual inspection of the low-resolution acrylamide gels is of nu-
merous bands (Supplemental Fig. 5), whereas counting of se-
quenced clones suggests that one or a small number of variants
dominate (Supplemental Tables 3–5), plus some minor variants.
Nevertheless, MEG-1 displayed very distinct RT-PCR profiles
when samples derived from adult worms and schistosomula
were compared. A tally of clones from the two stages (Supple-
mental Table 4) revealed that isoforms 15–18 comprised 33% of
schistosomula and 0% of adult clones whereas isoforms 2–4 plus
7–14 comprised 16% of adult and 0% of schistosomula clones.
This observation suggests a specific stage-dependent mecha-
nism for generation of splice variants, rather than a random
process.
MEG-encoded proteins are secreted by migrating
schistosomula and mature eggs
During investigations on the schistosome proteome we identified
members of certain MEG families (Mathieson and Wilson 2010;
R Curwen, unpubl.). We therefore made a detailed analysis of the
relevant preparations, namely, the secretions of schistosomula and
mature eggs cultured in vitro. We also examined the tegument
surface membranes that comprise the interface between the adult
parasite and the host bloodstream. A two-dimensional (2D) elec-
trophoretic separation of the proteins released into culture by 0.5
million skin stage schistosomula between 3 h and 3 d (Supple-
mental Fig. 13; Fig. 5A) revealed a dominant cluster of gel spots
with variable shapes, which are the major secreted protein. (The
elongate spots may represent a group of proteins with similar pI
and Mr, not resolved by the electrophoresis.) A similar but weaker
staining pattern was observed in culture supernatants recovered
from lung stage schistosomula between 8 and 10 d (data not
shown). Excision of the spots and subjection of their tryptic digests
to MALDI TOF/TOF MS revealed that the cluster comprised two
members of the MEG-3 family, MEG-3.1 (three spots), and MEG-
3.2 (two spots) (Supplemental Table 6). ProQ Emerald staining of
gels failed to detect any glycan residues, so it is likely that the
cluster represents proteins with small differences in primary
sequence. Fainter spots in the cluster did not yield identities, but
probably represent scarcer isoforms.
Whereas viable schistosomula secrete very little protein when
they are developing and migrating through the vasculature, the
eggs of approximately the same biomass provide much more ma-
terial for MS/MS analysis. Nevertheless, accumulation of sufficient
egg-secreted protein (ESP) for analysis of the scarce proteins in
lectin-depleted samples required the recovery of;2.5 million eggs
from the livers of 250 mice. A 2D electrophoretic separation of the
egg secretions revealed two very dominant spots, comprising
>80% of the protein present, which correspond to two previously
described egg proteins Omega-1 (ESP1-2) (GenBank DQ013207;
Fitzsimmons et al. 2005) and ESP 3-6/IPSE (GenBank AF527011;
Schrammet al. 2003) plus a number of fainter spots (Supplemental
Fig. 14A; Mathieson and Wilson 2010). The dominant spots (both
of which represent non-MEG proteins) stained with both ProQ
Emerald and Sypro Ruby, confirming their glycosylated status,
but the minor spots stained only with Sypro Ruby. Depletion of
the two major glycoproteins by passage down a lectin column,
although not complete, produced considerable enrichment of the
scarcer spots (Supplemental Fig. 14B). All spots were excised from
the gel and their individual tryptic digests subjected to LC sepa-
ration and electrospray MS/MS to obtain maximum coverage of
the peptide composition. The vast majority of spots proved to be
MEG proteins, with three members of the MEG-3 (MEG-3.1,
MEG-3.2, and MEG-3.3) and five mem-
bers of the MEG-2 (MEG-2.1, MEG-2.2,
MEG-2.5, MEG-2.6, and MEG-2.8) fami-
lies identified (Fig. 5B; Supplemental
Table 6). The MEG-3 members showed
a greater diversity of position than in the
schistosomular preparations, with pI
ranging from 4 to 6 and Mr from 15 to
25 kDa. They occupied both distinct
spots and vertical smears on the gel, sug-
gestive of a diversity of isoforms present.
However, all peptides identified were
encoded by adjacent micro-exons with
no examples of exon skipping reaching
statistical significance (Supplemental Ta-
ble 6). The MEG-2 family members had
a lower average Mr ranging from 5 to 10
kDa and showed amuchwider pI, ranging
from 3 to 8 kDa. Nevertheless, the MEG-2
Figure 4. Alternate splice variants ofMEG-3.2. The deduced structure for sequenced transcripts of the
MEG-3.2 gene is displayed. Wide lines represent coding region for exons, medium lines represent UTR
regions, and narrow lines represent the introns. Exons generated by the use of an alternative splicing site
are shown in gray. Coding exons that are being read in a frame different from the most abundant
isoform (1) are shown as a hatched box. Exons are shown to scale, but for illustrative purpose intron
length is not proportional to size. Numbers above exons indicate exon size, and underlined values are for
exons generated by use of alternative splicing sites.
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members also showed some diversity of position on the gel, es-
pecially MEG-2.1 and MEG-2.2, which reflects the range of iso-
forms present. Only a single MEG protein, MEG-5, was identified
in the tegument membrane preparations from adult worms.
MEG transcripts and proteins are expressed in epithelia
and gland cells
As virtually all MEGs possessed a signal sequence indicating that
they encoded either secreted or membrane-anchored proteins, we
examined the sites of expression of a small number by WISH and
immunocytochemistry. (The mature egg was precluded due to the
permeability barrier to antibodies presented by its shell.) Expres-
sion ofMEG-4.2 andMEG-14 was detected in a very small discrete
area of the cercaria (Fig. 6A,D). The distribution of f-actin in
smooth muscle fibers revealed that this staining pattern is as-
sociated with the gut primordium (Fig. 6B,E). In accord with the
microarray data, expression of both MEGs had increased con-
siderably by 3 d of in vitro culture (Fig. 6C,F). However, it was
not possible to say whether the precise site lay in the developing
gut caecae, the nascent esophageal gland, or both. Expression of
a second MEG-4 family member was investigated in adult worms,
where much greater resolution is possible. High-level expression
of MEG-4.1 was confined to the esophageal gland (Fig. 6H) that
lies ventral to the posterior esophagus, into which its secretions
empty. This localization was confirmed by the presence of MEG-4.1
protein in the glands and also in the esophageal lumen, detected by
specific antibody to a synthetic peptide (Fig. 6I). Finally, expression
of MEG-3.2 transcripts was identified in a very discrete area at the
extreme anterior of the schistosomulum (Fig. 6G). This lies within
the muscular head capsule and corresponds to the head gland, se-
cretions from which are used in skin and intravascular migration.
Discussion
Here, we characterize a novel class of genes with a unique structure
that code for secreted proteins in schistosomes. Previously, micro-
exons have largely been described as occurring singly in geneswith
normal-sized exons (Volfovsky et al. 2003). Apparently, MEGs are
restricted to schistosomes, as no homologous proteins could be
found in other genera, despite intensive computational searches in
public databases that included genomes and EST data from other
Platyhelminthes. The absence of homology with proteins from
any other organism and the lack of any known protein domain
prevented us from computationally assigning any function to
this obviously diverse range of proteins, other than their likely
secretion from cells.
Our data suggest a mechanism for acquisition and diversifica-
tion of micro-exons by duplication or recombination of genomic
segments containing micro-exons and modification of micro-exon
lengths by point mutation events generating new splicing sites.
Notably, most of themodifications observed inMEG-3 family gene
structure occur at their extremities, suggesting that an evolution-
ary pressure must exist to restrict disruptive modifications at the
core of the protein. In a particular case, the duplication of one exon
was apparently associated with the insertion of a retroelement with
viroid-like characteristics; such elements are mainly represented in
plants but have been previously described in schistosomes (Ferbeyre
et al. 1998). It is still unclear if these exon duplications are somehow
triggered by events of transposition, but if this is the case the high
transcription levels of some retroelements in S. mansoni (DeMarco
et al. 2004) may constitute a catalyst for evolutionarymodifications
of MEG structure. The intricate structure of MEGs is by no means
a trivial one to acquire and maintain, and we speculate that some
adaptive advantage must arise from such a structure. Moreover,
some of the families had an expansion in the number of members
as a result of several gene duplication events. Some of these ex-
pansions were quite recent, as demonstrated by the strong simi-
larity of the genomic regions for three MEG-3 family members.
The absence of this class of genes in other platyhelminths
suggests that a rapid appearance and expansion must have oc-
curred in an ancestor located at a basal position of the Schistosoma
genus, thus representing an adaptation to parasitism. Considering
that scenario, we hypothesize that the development ofmicro-exon
genes in schistosomes resulted fromthe expansionof a few ancestral
micro-exons that were reiteratively duplicated andmutated in order
to generate the multiple micro-exons observed in these genes.
Together with gene duplication events, this mechanism could ex-
plain the emergence of the numerous families. Considering that
similarities between proteins coded by genes of different families
are very low, we must assume that mutation rates in MEGs are
quite high. In fact, examining the MEG-3 family, the identity
observed between the MEG-3.4 protein product and the other
Figure 5. MEG-encoded proteins are secreted by migrating schistosomula and mature eggs. (A) 2D electrophoretic separation of secretions released
from skin-stage schistosomula between 3 h and 3 d of in vitro culture. (B) 2D electrophoretic separation of the less abundant egg-secreted proteins (ESPs)
after lectin depletion of themajor ESP1-6 proteins. Spot numbers inside the block arrows (A) or circles (B) correspond to theMS data in Supplemental Table
6. The MEG family number is adjacent to each spot or spot group.
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members of the family is low (;26%), despite the very similar
gene structure depicted in Figure 2. The assembly of a micro-exon
gene from multiple sources of micro-exons combined with the
high mutation rates in the small sized exons would create new
families that in relatively short timewould not resemble any of the
parent sources of micro-exons.
RT-PCR experiments of selected MEGs showed that some
copies of the genes produce numerous splice variants. Such events
provide an explanation formaintenance of small symmetrical exons,
since they permit small portions of a transcript be removed without
disrupting the reading frame. As a result, we anticipated that trans-
lation of such variant transcripts would generate several protein
isoforms from each MEG, most of them with very small differ-
ences in molecular weight and pI. In fact, in the secretions of eggs
and migrating schistosomula we found just that. We detected
multiple gel spots that were identified as proteins coded by five
copies of MEG-2 and three of MEG-3. Considering the variable
appearance of the spots and the resolution of 2D electrophoresis,
it is very unlikely that all isoforms were individually separated
suggesting that each spot/smear represents one to several isoforms.
Trypsinization of a mixture of isoforms contained in a single spot
would create a pool of peptides for MS/MS in which the more
commonpeptideswouldpredominate relative to those representing
an arrangement less represented in the pool. This may explain why
we have so far been unable to identify exon-skipping peptides di-
agnostic for single splice variants in ourmass spectrometric analysis
at an acceptable level of statistical significance, detecting only more
abundant peptides which represent portions coded by adjacent
exons. It is not possible to make a clear correlation between the
abundance of the spots in the 2D gel and the count of DNA clones,
which suggests that translational controls may be occurring to in-
fluence the abundance of proteins. Moreover, cloning of cDNA is
not a totally unbiased process and some messages may be under/
overrepresented, depending on several factors.
Finally, the MEGs largely encode secreted proteins and we
have confirmed for a small number that they are expressed in ep-
ithelia and gland cells. Many of the MEG transcripts are up-regu-
lated in stages involved in skin penetration, and intravascular
migration during which the parasite gut develops to initiate blood
feeding. In the case of the schistosome egg, theMEG-2 andMEG-3
variants are particularly prolific andmay be involved in egg transit
from the blood vessel to the lumen of the host gut. (In this context,
it is important to establish where the rest of the MEG proteins are
expressed.) All the above are situations where MEG proteins can
interact with the host immune system.
Schistosomes are unusual among parasitic platyhelminths in
dwelling in themammalian bloodstream,where they are bathed in
antibodies and complement and surrounded by leukocytes. The
generation of variant proteins (and hence antigens) as a strategy to
evade host immune responses is a recurrent theme in the analogous
protozoan blood parasitesTrypanosoma and Plasmodium (Taylor and
Rudenko2006; Kyes et al. 2007). It is thus tempting to conclude that
the protein variation we have described in schistosomes is similarly
one component of an immune evasion strategy, conferring some
benefit on the parasite. However, there are significant differences
between schistosomes and the two protozoans. The schistosome
variant proteins are produced simultaneously, not sequentially.
In addition, there is currently no evidence for the distribution of
allelic variants of MEGs across schistosome populations. If the
generation of protein variation by expression of MEGs is a strategy
for immune evasion, then a different underlying mechanism is
implicit in schistosomes. Nevertheless, the extent ofMEG transcript
and protein variation suggests some form of pressure is exerted to
select for micro-exon persistence when it has appeared, potentially
by the immune system. The ramifications of MEG diversity in the
context of immune evasion are a subject for future work. Individual
schistosomes can survive in the bloodstream for >30 yr (Harris et al.
1984) and do not possess intracellular stages that would be pro-
tected fromhost immune attack. Itwould be expected that strategies
to ensure long-term immune evasion by using protein variation in
schistosomeswould not be the same of those observed in protozoan
parasites, where need for long-term immune evasion is less imper-
ative since either elimination of the infection or death of the host
occurs on a much shorter time span.
Figure 6. Whole-mount in situ hybridization (A,C,D,F–H ) and immu-
nocytochemistry (C,E,I ) to identify the location of selected MEG gene
expression products. (A) Focal expression of MEG-4.2 associated with the
gut primordium of the nonfeeding infective cercariae, lying on its back.
The fine dashed lines indicate the positions of the muscular head capsule
and gut to aid interpretation. (B) The position of the embryonic esophagus
and gut in a cercaria with similar orientation, revealed by Phalloidin
staining of actin in the surrounding myocytes. (C ) Increased expression of
MEG-4.2 in the day 3 (skin stage) schistosomulum. (D) Focal expression of
MEG-14 in a cercariae lying on its side, with structures outlined as in A. (E )
A phalloidin stained day 3 schistosomulum in the same orientation to aid
interpretation. Note that myocytes around the gut show only minimal
expansion of the organ. (F ) Increased expression ofMEG-4.2 in the day 3
schistosomulum. (G)MEG-3.2 transcript expression sharply demarcated in
the head gland (hg) of a day 10 (lung stage) schistosomulum. (H ) Ex-
pression of MEG-4.1 in the esophageal gland (og) that envelops the
ventral aspect of the esophagus (o). The gland lies adjacent to the ventral
sucker (vs) distal to themouth and oral sucker (os). (I ) Confocal projection
of MEG-4.1 protein detected in the male esophageal gland (og) using
antibody to a synthetic peptide; traces of protein are also present in the
esophageal lumen (arrowhead). The nuclei are counterstained with DAPI
to reveal body outline. Magnifications: A,B,D,E all approximately the
same, bar, 20 mm; C,F, bar, 50 mm; G–I, bars, 20 mm.
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Methods
Biological material
Infective cercariae from a Puerto Rican isolate of S. mansoni were
shed from Biomphalaria glabrata snails by exposure to bright light.
Adult worms were obtained by portal perfusion of C57BL/6 mice
7 wk after percutaneous infection with 180 cercariae. Eggs were
recovered from female NMRImouse livers by trypsin digestion and
then cleaned by washing and sieving in PBS (Ashton et al. 2001).
Schistosomula were derived from samples of 0.5 million cercariae,
mechanically transformed, and cultured in vitro in 24-well plates
for up to 10 d, as required (Dillon et al. 2006). The schistosomula
need a protein supplement in the medium to develop normally
and retain viability but this is incompatible with proteomic anal-
ysis. The problem was solved by short-term culture in medium
containing human serum albumin (HSA) at 10 mg/mL concentra-
tion, either between 3 h and day 3 or day 8 and day 10. Viability of
parasites under these culture conditions was checked by trypan
blue exclusion and by visual inspection for lack of motility and
’’granular appearance’’ to indicate death; it was found to be the
same as with addition of fetal calf serum over a similar period. A
single culture of 0.5 million schistosomula, distributed between
eight 24-well plates at 1.5 mL medium per well, yielded ;300 mL
of medium containing 2.9 mg of HSA. This was depleted from the
culture supernatant using a cartridge containing POROS perfusion
chromatography medium coupled to goat anti-human albumin
IgG (a gift from Applied Biosystems), with a binding capacity of
2 mg/mL and a total volume of 1.4 mL. The manufacturer’s rec-
ommendations not to exceed 50% of the binding capacity of the
cartridge were adhered to so a single culture supernatant was split
into two or three subsamples, according to its protein content, for
HSA depletion, with intervening cartridge regeneration steps. Egg-
secreted proteins were collected by incubating mature eggs in se-
rum-free RPMI (GIBCO) for two periods of 3 d with a medium
change interposed (Ashton et al. 2001; Mathieson and Wilson
2010). Post-culture viability of eggswas routinely >96%, as assessed
by observation of muscular and flame cell activity in unhatched
miracidia. Germball progenitors of cercariae, derived fromdaughter
sporocysts, were carefully dissected from snail hepatopancreas 22 to
26 d after infection with 40 miracidia per snail.
Microarray experiments
Integral to a study of changes in gene expression associated with
infection of the mammalian host we designed a comprehensive oli-
gonucleotide microarray comprising a compilation of the S. mansoni
gene predictions on GeneDB (http://www.genedb.org/genedb/
smansoni/) together with expressed sequence tag (EST) contig
assemblies available on the Wellcome Trust Sanger Institute
(WTSI) ftp site (ftp://ftp.sanger.ac.uk/pub/pathogens/Schistosoma/
mansoni/) (Manuel 2010), that was manufactured by Roche/
Nimblegen. Samples of total RNA were extracted with TRIzol
(Invitrogen) following manufacturer’s instructions and high-salt
solution (0.8 M sodium citrate and 1.2 M NaCl) was added with
the isopropanol to remove glycoprotein. Using this protocol, RNA
was extracted from three biological replicates of the intramolluscan
germ balls, cercariae, schistosomula transformed from cercariae and
cultured in vitro for 3 d to the skin stage of development (Dillon
et al. 2006), and eggs (Mathieson and Wilson 2010). Double-
stranded cDNA was synthesized (without amplification) using a
SuperScript II kit (Invitrogen) according to the manufacturer’s
instructions, labeled with Cy3, and hybridized to the array over-
night at 42°C. Two-way comparisons were made of gene expres-
sion levels in the three life cycle stages. Fluorescence intensity data
were normalized at the probe level, before being averaged for
each S. mansoni locus, analyzed using the Bioconductor package
(http://www.bioconductor.org/) and values that differed by a fold
change of two between stages with an adjusted P < 0.0001 and a
B-value > 3 (corresponding to a 95% confidence limit), were taken
as significant. Expression of MEGs in eggs was assessed against
the level in the cercaria, set at unity.
RT-PCR and cloning of MEG transcripts
Approximately 400 ng of mRNA from 7-d cultivated schistosom-
ula, adult worms, and eggs were treated with 5 U of RQ1 RNase-
free DNase (Promega) for 30min at 37°C.DNase-treatedmRNAwas
separated into two aliquots, one being used for RT-PCR and the
other for a no-RT parallel negative control in which the same re-
agents of the normal reaction were added, except for the reverse
transcriptase. Reverse transcription was performed with 50 U of
Superscript II (Invitrogen) and 0.5 mg of poly-dT primer in a 20-mL
volume for 60 min at 42°C. The PCR step was performed with
Advantage II polymerase (Clontech) with buffer supplied by the
manufacturer, 1mL of reverse transcription reaction and 200 nMof
each primer using the following program: 94°C (1 min); 35 cycles
of 94°C (30 sec), 55°C (30 sec), and 68°C (5min); final extension of
68°C (5 min). PCR products were submitted to electrophoresis in
polyacrylamide gel and stained by silver using a previously de-
scribed protocol (Sanguinetti et al. 1994). Products were cloned
into pGem-T vector (Promega) and resulting clones stocked in TB-
ampicillin. Colony PCR was performed using Biolase DNA poly-
merase (Bioline), 10 pmol of each specific internal primer and the
following cycling: 94°C (5 min), plus 40 cycles of 94°C (30 sec),
57°C (45 sec), 72°C (1min), and final extension of 72°C for 5 min.
Resulting products were sequenced by the dideoxyterminator
method using primers for both extremities of the clone.
Resulting sequences for each clone were individually assem-
bled using the phredphrap package andwere compared against each
other after multiple alignment using the ClustalX program (Larkin
et al. 2007). Sequences were separated into groups representing
each splice variant. One sequence representative of each groupwas
chosen andmapped into the genome sequence for deduction of its
structure using the Spidey program (Wheelan et al. 2001), followed
by manual curation. A representative sequence for each isoform
was submitted to GenBank under accession numbers GU258169–
GU258215 and GU258219
Cloning and sequencing of genomic regions of MEG-3
To obtain a complete sequence for the MEG-3 family, PCR from
genomic DNAwas performed using primers flanking existing gaps
in the gene sequences. All primers designed were aligned against
the genome sequence from S. mansoni using the BLASTN program
and the result verified to assure that theymapped perfectly only to
the desired position in the genome. The PCR step was performed
with Advantage II polymerase (Clontech) with buffer supplied by
the manufacturer, 100 ng of genomic DNA, and 200 nM of each
primer using the following program: 94°C (1 min); 35 cycles of
94°C (30 sec), 55°C (30 sec), and 68°C (5 min); final extension of
68°C (5 min). Resulting amplicons were cloned and sequenced.
These genomic sequences were deposited in GenBank under the
accession numbers GU258216–GU258218.
Proteomics
Sample preparation
Culture medium containing ESPs was gravity-filtered through
0.2-mm filters then concentrated in Vivaspin-20, 5-kDa cutoff,
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centrifugal concentrators (both Sartorius, Fisher Scientific). Sam-
ples containing 75–500 mg of soluble protein were fractionated
by standard 2D electrophoresis techniques (Curwen et al. 2004).
Culture medium containing ESPs was first replaced by dialysis
for 18 h at 4°C into 20 mMTris-HCl (pH 7.2) (Sigma) using a Slide-
A-Lyzer dialysis unit (Pierce), concentrated to less than 20 mL with
an Amicon Ultrafree centrifugal concentrator (Millipore) and then
diluted in rehydration buffer to a total of 125 mL. All preparations
were separated by isoelectric focusing (IEF) on 7-cm, pH 3–10, IEF
strips (Amersham Biosystems), under the following conditions: 15
h rehydration, then 500 V (30min), 1000 V (30min), and 8000 V
(4 h) (at 50 microA per strip). The strips were then reduced, alkyl-
ated, and separated by molecular mass on 4%–12% SDS-PAGE gels
(Invitrogen). The gels were fixed in 40%methanol/10% acetic acid
solution and stained initially with ProQ Emerald for glycans and/
or Sypro Ruby for proteins (Invitrogen), according to the manu-
facturer’s instructions, prior to imaging on a Versadoc Imaging
System Model 3000 (Bio-Rad), and then with Biosafe Coomassie
(Bio-Rad) prior to excision of spots. ESPs of low abundance were
enriched using the previously demonstrated affinity of the major
protein, IPSE, for Aleuria aurantia lectin (Schramm et al. 2003), as
adapted by Mathieson and Wilson (2010). A 460-mg aliquot of
crude ESP (;1 mL) was applied to the lectin column and the ef-
fluent (containing lectin-depleted ESP) collected over four column
volumes. It was then processed for 2D electrophoretic separation
on 7-cm gels as previously described (Mathieson andWilson 2010).
‘‘Flow-through’’ fractions from the HSA depletion column
were assessed for protein concentration by the Coomassie Plus
assay (Pierce), and those containing schistosomular-secreted pro-
teins were combined. They were concentrated ;30-fold using a
Vivaspin 20 (5 kDa cutoff) spin column before desalting prior to
separation by 2D electrophoresis.
Tegument membranes were removed from adult worms by
a freeze/thaw method and surface membranes enriched by su-
crose-gradient centrifugation as previously described (Roberts et al.
1983). They were pelleted by centrifugation at 100g for 30 min at
4°C, resuspended in 0.5 mL of 10 mM Tris, and enriched on
a continuous 20%–70% sucrose gradient, with centrifugation at
100,000g for 40 min. The fractions containing alkaline phos-
phatase activity (an apical membrane marker) were pooled and
centrifuged at 100,000g for 1 h to produce a ‘‘gradient pellet’’
highly enriched in surface membranes. Proteins were sequentially
extracted from the gradient pellet using a three-step process with
reagents of increasing solubilizing power to yield a final pellet
(Braschi et al. 2006), whichwas solubilized in 200 mL of 0.1% SDS,
1% Triton X-100 in 20mMNH4HCO3, and digested overnight in-
solution with trypsin at an enzyme:substrate ratio of ;1:20. The
digestedmaterial was first separated by cation exchange and then
by reversed phase chromatography and collected directly onto
a MALDI plate as previously described (Braschi et al. 2006).
Protein digestion and MALDI-MS/MS
Gel pieces were destained with 40% methanol/10% acetic acid
solution, washed in 20 mM ammonium bicarbonate/50% acetoni-
trile solution, dehydrated in 100% acetonitrile, dried in a Speedvac
(Thermo Lifesciences), and digested into peptides overnight at 37°C
with 20 mL of 10 mg/mL sequencing grade porcine trypsin per gel
piece (Promega). The peptides were applied to C18 ZipTips (Mil-
lipore), desalted as per the manufacturer’s instructions, and eluted
in 5 mL of 80% acetonitrile/0.1% TFA solution. Twomicroliters of
the eluate were mixed with 1 mL of matrix solution (a-cyano-
4-hydroxycinnamic acid [Sigma] saturated in a 50% acetonitrile/
0.1% TFA solution) and dried onto a MALDI plate.
Tryptic peptides from schistosomular secretions, adult tegu-
ment, and the ESP before lectin depletion were analyzed on a 4700
MALDI-TOF/TOF mass spectrometer (Applied Biosystems) operat-
ing in positive ion reflector mode. A peptide mass fingerprint was
acquired from each spot using 1500 laser shots at 2800–3500 Vand
the 15 most intense peaks were selected for fragmentation (ex-
cluding common tryptic autolysis and human keratin peaks). The
MS/MS data were processed by GPS Explorer (Applied Biosystems)
and the resulting peak lists exported to Mascot v 2.1 (Matrix Sci-
ence). The search parameters were set so that only MS/MS frag-
mentation data with a tolerance <0.2 Da were used. One missed
cleavage was allowed for, as were carbamidomethylation modifi-
cations to the cysteine and oxidation of the methionine residues.
Databases searches were (1) NCBInr; (2) SchistoCDS, an in-house
database comprising clusters of all publicly available ESTs (Sm
numbers) plus gene predictions from version 1 of the S. mansoni
genome database (http://www.genedb.org); (3) Sm genes + ESTs
which superseded SchistoCDS when version 4 was loaded into
GeneDB; (4) Exon permutations. This last is a theoretical database
comprising all possible combinations of exons encoding MEG-3
and some MEG-2 family proteins. Created by Peter Ashton, it was
an essential tool to facilitate Mascot searching for exon skipping,
which would not be detected by the normal Mascot search algo-
rithm.Conventionalmatcheswere only accepted if the confidence
interval of the total peptide ion scores was >99.9%.
Electrospray tandem MS
In order to obtain better coverage, peptides derived from lectin-
depleted ESPs were subjected to electrospray tandemMS. Aliquots
(1–3 mL) of trypsin-digested spots were loaded onto an Ultimate
nano-HPLC system (Dionex) equipped with a PepMap C18 trap
(Dionex), previously equilibrated and washed with 0.1% (v/v)
formic acid, and an Onyx C18 monolithic silica capillary column
(Phenomenex). A gradient elution of sample was achieved by the
sequence: initial eluant 100% Solvent A (2% [v/v] acetonitrile,
0.1% [v/v] formic acid in H2O) for 3 min, trap switched, a 0%–
50% linear gradient of Solvent B (pure acetonitrile, 0.1% [v/v]
formic acid) for 20 or 60 min, a 5-min wash at 95% Solvent B, all
at a flow rate of 1.2 mL/min and column temperature 60°C. Con-
trol and data acquisition were with Chromeleon v6.6 software
(Dionex). The HPLC was interfaced with a QSTAR API Pulsar i Hy-
brid LC/MS/MS System (Applied Biosystems) with a MicroIonSpray
source (fitted with a 20-mm ID capillary). Positive ESI MS and
MS/MS spectra were acquired over the range 350–1800 m/z us-
ing information dependent acquisition with instrument, data ac-
quisition, and analysis controlled by Analyst QS v1.1 software. MS
and MS/MS data were searched as for MALDI, above.
Whole-mount in situ hybridization and immunocytochemistry
For whole-mount in situ hybridization (WISH), parasites were
fixed and processed as described by Dillon et al. (2007). The
preparation of digoxygenin-labeled probes, the conditions for
in situ-hybridization, and detection of expression sites were also
as previously described (Dillon et al. 2007). The substrates BM
purple and Fast Red TR were used for conventional light and
confocal microscopy detection, respectively. Nuclei were stained
with 49,6-diamidino-2-phenylindole (DAPI) where confocal
microscopy was used.
For visualization of the musculature by f-actin, larvae were
stained with Alexafluor 488-conjugated phalloidin (Invitrogen,
Molecular Probes) and counterstained with DAPI according to the
protocol of Bahia et al. (2006). Specimens were fixed for 1 h in 4%
paraformaldehyde in phosphate buffered saline (PBS) on ice and
then permeabilized for 1 h in PBS, 0.2% gelatin, 0.1% saponin,
0.1% NaN3 at room temperature, before staining, and washed
several times in PBS before viewing. For detection of MEG-4.1 in
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adult worms, an antibody was raised by vaccinating rats with
a synthetic peptide (CPKSIADIFLINKPKVP-OH derived from the
protein sequence and coupled via the cysteine to carrier ovalbu-
min), emulsified in Titermax Gold (Sigma-Aldrich), and sub-
sequently boosted at 3 wk with conjugate alone. Whole adult
worms were fixed and permeabilized using the protocol described
by Mair et al. (2000) prior to reaction with primary antibody, ex-
tensive washing, and detection of localization by Alexa-fluor 488
labeled goat-anti rat antibody (Sigma). They were counterstained
with DAPI before examination under a LSM 510 Meta confocal
microscope (Zeiss).
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